Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of irritable bowel syndrome.

Literature DB >> 15731122

Treatment of irritable bowel syndrome.

Michael J G Farthing.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 15731122 PMCID： PMC549640 DOI： 10.1136/bmj.330.7489.429

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

11 in total

1. Epidemiology of ischaemic colitis.

Authors: A Brinker; M Avigan
Journal: Aliment Pharmacol Ther Date: 2004-09-15 Impact factor: 8.171

2. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.

Authors: M Camilleri; W Y Chey; E A Mayer; A R Northcutt; A Heath; G E Dukes; D McSorley; A M Mangel
Journal: Arch Intern Med Date: 2001-07-23

Review 3. Treatment options in irritable bowel syndrome.

Authors: Michael J G Farthing
Journal: Best Pract Res Clin Gastroenterol Date: 2004-08 Impact factor: 3.043

Review 4. Tegaserod for the treatment of irritable bowel syndrome.

Authors: B W Evans; W K Clark; D J Moore; P J Whorwell
Journal: Cochrane Database Syst Rev Date: 2004

5. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Authors: Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala
Journal: Gastroenterology Date: 2003-07 Impact factor: 22.682

Treatment of irritable bowel syndrome.

1. Epidemiology of ischaemic colitis.

2. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.

Review 3. Treatment options in irritable bowel syndrome.

Review 4. Tegaserod for the treatment of irritable bowel syndrome.

5. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Review 6. Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome.

7. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome.

8. Self-management for women with irritable bowel syndrome.

Review 9. Evolving pathophysiologic models of functional gastrointestinal disorders.

Review 10. Systematic review: the epidemiology of ischaemic colitis.

1. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.

2. Characterization of irritable bowel syndrome and constipation in children with allergic diseases.